← Open Payments lookup

BAYLEE RICHARDSON: Open Payments

NPI 1881392199 · BELZONI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$485 in 19 payments from 9 companies in 2025. Trend: 2023 $491 · 2024 $401 · 2025 $485

Food & beverage: $485
CompanyPaymentsAmount
Novo Nordisk Inc8$222
Lundbeck LLC3$80
AstraZeneca Pharmaceuticals LP2$39
Verona Pharma, Inc.1$30
ABBVIE INC.1$25
GlaxoSmithKline, LLC.1$24
Amgen Inc.1$23
Esperion Therapeutics, Inc.1$23
Boehringer Ingelheim Pharmaceuticals, Inc.1$20

Products named: Ozempic, REXULTI, Rybelsus, Ohtuvayre, VRAYLAR, TRELEGY ELLIPTA, OTEZLA, NEXLETOL.

Industry payments across MS — which companies pay providers there.